Dr. Reddy's launches sirolimus tabs

HYDERABAD, India — Dr. Reddy's Labs on Tuesday announced the launch of sirolimus tablets in 1-mg and 2-mg dosage strengths. The drug is the generic version of Rapamune. 

 

According to the Food and Drug Administration, Rapamune is indicated to prevent rejection in patients 13 years of age and older who have received a kidney transplant. Rapamune tabs had sales in the United States of $206 million for the 12 months ending August 2014, according to IMS Health. Dr. Reddy's sirolimus tabs are available in bottle counts of 100.